| Title | Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study. | | Author(s) | Arpin S, Lagrue E, Bodard S, Chalon S, Castelnau P | | Institution | UMRS INSERM U 930, CNRS ERL 3106, "Imagerie et cerveau", Tours, 37000, France. | | Source | Metab Brain Dis 2009 Sep 30. | | Abstract | The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model provides a valuable paradigm of the energy deficiency disorders found in childhood. In such disorders, anticonvulsants may provide neuroprotection by modulating cellular energy consumption and by exerting favorable pleiotropic effects on neuronal survival. To verify such hypothesis, we tested the effects of levetiracetam, vigabatrin, gabapentine, pregabaline, tiagabine, clonazepam and lamotrigine on neuroprotection in the MPTP mouse model. The membrane dopamine transporter (DAT) density, which provides a reliable index of dopaminergic neurons survival in the basal ganglia, was assessed by semi-quantitative autoradiography of the striatum. Unlike all other anticonvulsants tested, lamotrigine provided a significant and dose-dependent neuroprotection in these experimental conditions. Lamotrigine, a widely used and well-tolerated molecule in children, could provide neuroprotection in various energy deficiency disorders. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19789969 |
|
